Building and institutionalizing risk management into the pharmaceutical supply chain (Biotech)

Venue: Online Event

Location: Palo Alto, California, United States

Event Date/Time: Jun 02, 2011 End Date/Time: Jun 02, 2011
Report as Spam


This webinar aims to get at the heart of why we are experiencing increasingly dysfunctional outcomes within the supply chains for pharmaceutical and biopharmaceutical products. The seeds of these issues are sown early on, in drug discovery and development, and carry-on forward into today's complex commercial supply chains. To counter this concerning trend, the webinar discusses how scientific, technical and managerial staff can build and institutionalize risk management approaches (as advocated in ICH Q9) into the drug development and commercialization process.

Learning Objectives:

- Develop a ‘root cause' view of the reasons for supply chain risk in the industry and the specific corrective and preventative actions (CAPA) required to put things right.
- Identify how critical activities, undertaken in early stage drug discovery and development, can play a pivot role in reducing risk. This includes exploring how QbD/PAT can be an important enabler.
- Discover effective strategies whereby industry practitioners can personally influence superior supply chain outcomes through the support and application of professional supply chain management (SCM) competencies.
- Learn how to harness powerful models in Strategic Procurement, to build strong suppler relationships and cross-business alliances, delivering greater end-to-end supply chain visibility/traceability, more effective change control and improved resource productivity.

Areas Covered in the Seminar:

- Understand the process of risk management as recommended by the International Conference on Harmonisation (ICH) guidance on Risk Management, ICH Q9, and the associated benefits of using such an approach.
- Be able to link their own particular circumstances to the wider product development and business environment risks, so as to maximise their own personal contribution to the organisation and also the contributions of colleagues.
- Have a clear understanding of the Regulatory expectations for risk management in the pharmaceutical industry of the 21st century.
- Develop an integrated view of risk through the application of powerful tools and processes that result in full ‘buy-in' to mitigation plans from key stakeholders.
- Take back to their work setting new approaches towards risk and ways of operating in project team and wider organizational issues.
- Learn how the application of supply chain management (SCM) competencies can dramatically reduce risk of failure in the supply chain.
- Feel far more confident that they understand risk management as an integral part of their regular operations, rather than an ad hoc event.

NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.


Online Event
2600 E. Bayshore Road
Palo Alto
United States